WASHINGTON (Reuters) - Cheaper generic drugs will continue to hold down costs for the U.S. government, insurers and patients enrolled in the federal prescription drug benefit, according to a report released on Friday.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/WID-EDoGBP0/us-medicare-part-d-idUSTRE76E61V20110715
Weight Loss Womens Issues Health and Fitness Acne Acupuncture Aerobics Cardio
No comments:
Post a Comment